Synpromics announces £5.2M British investment in gene therapy tech – BioPharma-Reporter.com
BioPharma-Reporter.com |
Synpromics announces £5.2M British investment in gene therapy tech
BioPharma-Reporter.com The promoters allow for precise control of gene function, impacting gene therapy, cell therapy and gene editing. Synpromics CEO David Venables described the distinct nature of the PromPT platform late last year as a “unique capability for the … Synpromics Raises £5.2M of New InvestmentYahoo Finance Biotech firm Synpromics secures £5.2m cash injectionThe Scotsman |
OncLive |
Dr. Monk on Immunotherapy for Gynecologic Cancer
OncLive Bradley J. Monk, MD, FACOG, FACS, professor, director of the Division of Gynecologic Oncology at Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona, discusses immunotherapy for patients with … |
Wall Street Pit |
New ‘CRISPR Pill’ Could Replace Antibiotics
Wall Street Pit CRISPR-Cas9 is currently the most widely used version of CRISPR. But just recently, a new variant has been added to its toolbox — CRISPR–Cpf1 — which scientists demonstrated could correct mutations that cause a condition called Duchenne muscular … |
Wall Street Pit |
New ‘CRISPR Pill’ Could Replace Antibiotics
Wall Street Pit CRISPR-Cas9 is currently the most widely used version of CRISPR. But just recently, a new variant has been added to its toolbox — CRISPR–Cpf1 — which scientists demonstrated could correct mutations that cause a condition called Duchenne muscular … |
Genetic Engineering & Biotechnology News |
Stem Cells Primed to Be on Alert to Repair Tissue Damage | GEN
Genetic Engineering & Biotechnology News Researchers identify molecular signal that prepares stem cells to serve as a therapy to improve wound healing. |
Blive |
Researchers use CRISPR technology to create new strain of red-eyed mutant wasps
News-Medical.net Researchers at UC Riverside’s Akbari lab have brought a new strain of red-eyed mutant wasps into the world. The wasps were created to prove that CRISPR gene-slicing technology can be used successfully on the tiny parasitic jewel wasps, giving … Red-eyed mutant wasps created in lab for first timeThe Independent In A First, Red-Eyed Mutant Wasps Created in LabBlive |
|
Cobra Biologics embarks on £15 million gene therapy manufacturing expansion
The Pharma Letter (registration) Cobra Biologics, an international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals, is to expand operations at its sites in the UK and Sweden to meet the increased demand of gene and immunotherapy … |
|
Cobra Biologics embarks on £15 million gene therapy manufacturing expansion
The Pharma Letter (registration) Cobra Biologics, an international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals, is to expand operations at its sites in the UK and Sweden to meet the increased demand of gene and immunotherapy … |